Prognostic impact of CEBPA mutational subgroups in adult AML.
Journal Information
Full Title: Leukemia
Abbreviation: Leukemia
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Evidence found in paper:
"the information collected included complete sequencing results (performed either by sanger sequencing or next generation sequencing; ngs) of the entire cebpa gene (genbank accession no. nm_004364 2)."
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests C.T. is CEO and co-owner of AgenDix GmbH; all other authors have nothing to disclose."
Funding Disclosure
Evidence found in paper:
"Funding Open Access funding enabled and organized by Projekt DEAL."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025